2026
S.
Klapa,
K.
Bieber,
A.
Vorobyev,
M.
Ludwig,
G.
Vollert,
S.
Arnold,
H.
Olbrich,
H.
Nording,
A.
Müller,
K.
Kridin,
J.
Schirmer,
K.
Allwördern,
A.
Staehle,
R.
Ludwig, and
P.
Lamprecht,
ANCA-associated vasculitis is associated with an increased risk of cardiac and vascular morbidity: results of a large-scale propensity-matched global retrospective cohort study, Frontiers in Immunology , Apr. 2026.
ANCA-associated vasculitis is associated with an increased risk of cardiac and vascular morbidity: results of a large-scale propensity-matched global retrospective cohort study, Frontiers in Immunology , Apr. 2026.
| DOI: | 10.3389/fimmu.2026.1794549 |
K.
Sinning,
M.
Eckstein,
X.
Zhao,
A.
Rosenfeldt,
S.
Hochrein, and
M.
Vaeth,
The Glucose Transporter GLUT3 Controls Regulatory T Cell Function, bioRxiv , Mar. 2026.
The Glucose Transporter GLUT3 Controls Regulatory T Cell Function, bioRxiv , Mar. 2026.
| DOI: | 10.64898/2026.03.26.714439 |
A. Hutloff,
Selective Complement Inhibition in , Cellular & Molecular Immunology , Mar. 2026.
Selective Complement Inhibition in , Cellular & Molecular Immunology , Mar. 2026.
| DOI: | 10.1038/s41423-026-01400-3 |
A.
Mahdy,
Z.
Taheri,
M.
Hoivik,
A.
Franke, and
H.
ElAbd,
High throughput profiling of the B cell repertoire identifies systemic changes in the repertoir of individuals with Crohn's disease, Frontiers in Immunology , Feb. 2026.
High throughput profiling of the B cell repertoire identifies systemic changes in the repertoir of individuals with Crohn's disease, Frontiers in Immunology , Feb. 2026.
| DOI: | 10.3389/fimmu.2026.1725813 |
S.
Gonther,
M.
Thieme,
G.
Gubert,
P.
Schilf,
A.
Derenda-Hell,
S.
Murthy,
M.
Hirose,
M.
Vaeth, and
C.
Sadik,
Moxifloxacin Inhibits Neutrophil Responses to Immune Complexes and Ameliorates Skin Inlfammation in a Model of Pemphigoid Diseases, Federation of American Societies for Experimental Biology , Feb. 2026.
Moxifloxacin Inhibits Neutrophil Responses to Immune Complexes and Ameliorates Skin Inlfammation in a Model of Pemphigoid Diseases, Federation of American Societies for Experimental Biology , Feb. 2026.
| DOI: | 10.1096/fj.202503040RR |
Y.
Mehrjerdian,
R.
Atallah,
B.
Wijaya,
C.
Hammers,
S.
Gerdes, and
G.
Heine,
Case Reports: Dupilumab in difficult-to-read bullous pemphigoid at the University Hospital Schleswig-Holstein, Campus Kiel, Frontiers in Medicine , Jan. 2026.
Case Reports: Dupilumab in difficult-to-read bullous pemphigoid at the University Hospital Schleswig-Holstein, Campus Kiel, Frontiers in Medicine , Jan. 2026.
| DOI: | 10.3389/fmed.2025.1697048 |
S.
Emtenani,
T.
Lari,
C.
Kiehne,
N.
Beek,
M.
Holtsche, and
E.
Schmidt,
Selective Complement Inhibition in Anti-p200 Pemphigoid: Immune Infiltrate Profiles and Therapeutic Implications Compared to Bullous Pemphigoid, biomolecules , Jan. 2026.
Selective Complement Inhibition in Anti-p200 Pemphigoid: Immune Infiltrate Profiles and Therapeutic Implications Compared to Bullous Pemphigoid, biomolecules , Jan. 2026.
| DOI: | 10.3390/biom16020182 |
H.
ElAbd,
A.
Mahdy,
E.
Wacker,
M.
Gretsova,
D.
Ellinghaus,
A.
Dempfile, and
A.
Franke,
T cell receptor clonotypes predict human leukocyte antigen allele carriage and antigen exposure history, Communications Biology , Jan. 2026.
T cell receptor clonotypes predict human leukocyte antigen allele carriage and antigen exposure history, Communications Biology , Jan. 2026.
| DOI: | 10.1038/s42003-025-09140-2 |
2025
S.
Kaiser,
I.
Suhrkamp,
J.
He,
C.
Helf,
C.
Sadik,
M.
Weichenthal, and
G.
Heine,
Bexarotene signaling in human B and T lymphocytes induces gut-homing receptor expression, Frontiers in Immunology , Oct. 2025.
Bexarotene signaling in human B and T lymphocytes induces gut-homing receptor expression, Frontiers in Immunology , Oct. 2025.
| DOI: | 10.3389/fimmu.2025.1664199 |
X.
Liu,
S.
Patzelt,
Y.
Ma,
A.
Cepic,
H.
Dikmen,
K.
Bieber,
M.
Groussin,
M.
Poyet,
S.
Ibrahim,
E.
Schmidt, and
J.
Baines,
Gut Microbiota Modulates and Predicts Disease Severoty in Experimental Pemphigoid Disease, bioRxiv , Oct. 2025.
Gut Microbiota Modulates and Predicts Disease Severoty in Experimental Pemphigoid Disease, bioRxiv , Oct. 2025.
| DOI: | 10.1101/2025.10.01.679837 |
S.
Patzelt,
R.
Engin,
K.
Drenovska,
C.
Kiehne,
C.
Probst,
L.
Komorowski,
S.
Mindorf,
M.
Daneshpazhooh,
S.
Kim,
F.
Farnetani,
C.
Vaschieri,
R.
Rao,
A.
Marzano,
M.
Dmochowski,
A.
Patsatsi,
D.
Murrell,
J.
Kern,
H.
Kisla,
E.
Sprecher,
D.
De,
G.
Zenzo,
L.
Borradori,
H.
Jedlickova,
X.
Zhu,
E.
Schmidt, and
S.
Goletz,
Standardized indirect immunoflourescence-based detection of dermal-binding autoantibodies in pemphigoid diseases: a prospective international multicentre study, British Journal of Dermatology , Oct. 2025.
Standardized indirect immunoflourescence-based detection of dermal-binding autoantibodies in pemphigoid diseases: a prospective international multicentre study, British Journal of Dermatology , Oct. 2025.
| DOI: | 10.1093/bjd/ljaf385 |
N.
Gross,
A.
Jochimsen,
S.
Dräger,
T.
Theocharis,
A.
Recke,
N.
Beek,
L.
Schmidt-Jiménez,
S.
Krohn,
K.
Klausz,
K.
Bieber,
R.
Ludwig, and
M.
Peipp,
CD19xCD3 bispecific T cell engager treatment induces remission in experimental pemphigoid disease, bioRxiv , Sep. 2025.
CD19xCD3 bispecific T cell engager treatment induces remission in experimental pemphigoid disease, bioRxiv , Sep. 2025.
| DOI: | 10.1101/2025.09.09.675030 |
M.
Buenning,
S.
Purusothaman,
S.
Symannek,
P.
Curman,
K.
Kridin,
E.
Schmidt,
K.
Bieber, and
R.
Ludwig,
Differential risks of venous thromboembolic events in pemphigus and pemphigoid diseases, Journal of the European Academy id Dermatology & Venereology , Aug. 2025.
Differential risks of venous thromboembolic events in pemphigus and pemphigoid diseases, Journal of the European Academy id Dermatology & Venereology , Aug. 2025.
| DOI: | 10.1111/jdv.70017 |
A.
Mahdy,
J.
Fuß,
S.
Franzenburg,
M.
Vollstedt,
Y.
Dolshanskaya,
Kokubun,
V.
Kriukova,
F.
Tran,
C.
Bang,
M.
Hoivik,
J.
Skieceviciene,
J.
Kupcinskas,
M.
Poyet,
A.
Franke, and
H.
ElAbd,
Quantifying The Impact of Bulk TCR-Seq Methodological Choices on The Profiled T Cell Repertoire, bioRxiv , Aug. 2025.
Quantifying The Impact of Bulk TCR-Seq Methodological Choices on The Profiled T Cell Repertoire, bioRxiv , Aug. 2025.
| DOI: | 10.1101/2025.08.05.668736 |
H.
Olbrich,
S.
Preuß,
K.
Kridin,
G.
Hernandez,
D.
Thaci,
R.
Ludwig, and
P.
Curman,
COVID-19 infection raises respiratory type-2 inflammation disease risk, whereas vaccination is protective, The Journal of Allergy and Clinical Immunology , Jul. 2025.
COVID-19 infection raises respiratory type-2 inflammation disease risk, whereas vaccination is protective, The Journal of Allergy and Clinical Immunology , Jul. 2025.
| DOI: | 10.1016/j.jaci.2025.07.030 |
L.
Bao,
C.
Guerrero-Juarez,
J.
Li,
M.
Pigors,
S.
Emtenani,
Y.
Liu,
A.
Mansini,
Y.
Wang,
A.
Ahmed,
N.
Ishii,
T.
Hashimoto,
B.
White,
S.
Green,
K.
Kunstman,
N.
Nowak,
C.
Cole,
M.
Sarkar,
J.
Gudjonsson,
M.
Virgilia,
M.
Sverdlov,
M.
McAlexander,
C.
McCrae,
C.
Nazaroff,
E.
Schmidt, and
K.
Amber,
IgG autoantibodies in bullous pemphigoid induce a pathogenic MyD88-dependent proinflammatory response in keratinocytes, nature communications , Jul. 2025.
IgG autoantibodies in bullous pemphigoid induce a pathogenic MyD88-dependent proinflammatory response in keratinocytes, nature communications , Jul. 2025.
| DOI: | 10.1038/s41467-025-62495-2 |
S.
Dräger,
C.
Kauderer,
S.
Meyhöfer,
L.
Dräger,
J.
Marquardt,
R.
Ludwig,
S.
Arndt,
K.
Boch, and
K.
Bieber,
Sita- and saxagliptin use and autoantibodies to autoimmune bullous diseases: A cross-sectional study, Journal of the European Academy of Dermatology & Venereology , Jun. 2025.
Sita- and saxagliptin use and autoantibodies to autoimmune bullous diseases: A cross-sectional study, Journal of the European Academy of Dermatology & Venereology , Jun. 2025.
| DOI: | 10.1111/jdv.20885 |
P.
Curman,
S.
Dräger,
H.
Olbrich,
G.
Hernandez,
K.
Bieber,
E.
Gaffal,
K.
Kridin,
S.
Szymczak, and
R.
Ludiwg,
Identifying common risk factors for primary cellulitis in a large-scale retrospective cohort study, Preprints with THE LANCET , May 2025.
Identifying common risk factors for primary cellulitis in a large-scale retrospective cohort study, Preprints with THE LANCET , May 2025.
K.
Yilmaz,
S.
Goletz,
C.
Hammers,
K.
Boch,
C.
Zeidler,
H.
Wiegmann,
E.
Bergmann,
T.
Lari,
O.
Dikmen,
N.
Härding,
R.
Strohal,
A.
Kleinheinz,
E.
Hadaschik,
N.
Beek,
S.
Ständer, and
E.
Schmidt,
Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series, Journal der Deutshen Dermatologischen Gesellschaft , May 2025.
Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series, Journal der Deutshen Dermatologischen Gesellschaft , May 2025.
| DOI: | 10.1111/ddg.15838 |
B.
Laffer,
M.
Ohms,
S.
Kenno,
P.
Tsui,
E.
Ehlers-Jeske,
W.
Song,
W.
Song, and
J.
Köhl,
Therapeutic targeting of alternative pathway and C5 but not C5a protects from disease development in a preclinical model of autoiummune blistering dermatosis, Frontiers in Immunology , Apr. 2025.
Therapeutic targeting of alternative pathway and C5 but not C5a protects from disease development in a preclinical model of autoiummune blistering dermatosis, Frontiers in Immunology , Apr. 2025.
| DOI: | DOI: 10.3389/fimmu.2025.1560468 |
S.
Schacht,
J.
Graffunder,
P.
Durek,
J.
Wehrenberg,
A.
Siracusa,
C.
Biese,
M.
Mashreghi,
K.
Thurley,
L.
Bauer, and
A.
Hutloff,
Activation and maturation of antigen-specific B cells in nonectopic lung infiltrates are independent of germinal center reactions in the draining lymph node, Cellular & Molecular Immunology , Apr. 2025.
Activation and maturation of antigen-specific B cells in nonectopic lung infiltrates are independent of germinal center reactions in the draining lymph node, Cellular & Molecular Immunology , Apr. 2025.
| DOI: | 10.1038/s41423-025-01285-8 |
S.
Stenger,
A.
Vorobjev,
K.
Bieber,
T.
Lange,
R.
Ludwig, and
J.
Hundt,
Insomnia increases the risk for specific autoimmune diseases: a large-scale retroperspective cohort study, Frontiers in Network Physiology , Apr. 2025.
Insomnia increases the risk for specific autoimmune diseases: a large-scale retroperspective cohort study, Frontiers in Network Physiology , Apr. 2025.
| DOI: | 10.3389/fnetp.2025.1499297 |
M.
Hibino,
T.
Filosi,
L.
Carrion,
E.
Porcu,
A.
Malhotra,
K.
Lüdtke-Buzug,
S.
Ibrahim,
Y.
Yamada, and
M.
Hirose,
An effective approach to modulate mitochondrial function in murine primary macrophages by a mitochondria-targeted nanocapsule, MITO-Porter, Biomedicine & Pharmacotherapy , Apr. 2025.
An effective approach to modulate mitochondrial function in murine primary macrophages by a mitochondria-targeted nanocapsule, MITO-Porter, Biomedicine & Pharmacotherapy , Apr. 2025.
| DOI: | 10.1016/j.biopha.2025.118019 |
H.
Wu,
M.
Prados, and
M.
Vaeth,
Metabolic Regulation of T Cell Exhaustion, Immune Discovery , Mar. 2025.
Metabolic Regulation of T Cell Exhaustion, Immune Discovery , Mar. 2025.
| DOI: | 10.70322/immune.2025.10005 |
M.
Tigges,
S.
Dräger,
I.
Piccini,
K.
Bieber,
A.
Vorobjev,
J.
Edelkamp,
M.
Bertolini, and
R.
Ludwig,
Pemphigoid disease model systems for clinical translation, Frontiers in Immunology , Mar. 2025.
Pemphigoid disease model systems for clinical translation, Frontiers in Immunology , Mar. 2025.
| DOI: | 10.3389/fimmu.2025.1537428 |
